Back
Predictive Oncology, Inc. 10K Form
Sell
13
POAI
Predictive Oncology, Inc.
Last Price:
$5.50
Seasonality Move:
-11.59%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-13 | 10Q | POAI/Predictive Oncology, Inc. Quarterly |
| 2020-06-11 | 10Q | POAI/Predictive Oncology, Inc. Quarterly |
| 2020-06-08 | 10Q | POAI/Predictive Oncology, Inc. Quarterly |
| 2020-04-01 | 10K | POAI/Predictive Oncology, Inc. Annual |
| 2019-11-15 | 10Q | POAI/Predictive Oncology, Inc. Quarterly |
| 2019-08-19 | 10Q | POAI/Predictive Oncology, Inc. Quarterly |
Receive POAI News And Ratings
See the #1 stock for the next 7 days that we like better than POAI
POAI Financial Statistics
Sales & Book Value
| Annual Sales: | $1.6M |
|---|---|
| Cash Flow: | $-1.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-100.94 |
| Price / Book: | 4.71 |
Profitability
| EPS (TTM): | -115.91070 |
|---|---|
| Net Income (TTM): | $-84M |
| Gross Margin: | $635.6K |
| Return on Equity: | -1065.31% |
| Return on Assets: | -1686.19% |
Predictive Oncology, Inc. Earnings Forecast
Key Predictive Oncology, Inc. Financial Ratios
-
The Gross Profit Margin over the past 17 years for POAI is 39.14%.
-
The Selling, General & Administrative Expenses for POAI have been equal to 547.24% of Gross Profit Margin.
-
The Research & Development expenses have been 1.60% of Revenue.
-
The Net Earning history of POAI is -668.81% of Total Revenues.
-
Per Share Earnings over the last 17 years have been positive in 13 years.
Predictive Oncology, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | POAI |
| CUSIP: | 74039M |
| Website: | predictive-oncology.com |
Debt
| Debt-to-Equity Ratio: | -0.02 |
|---|---|
| Current Ratio: | 0.01 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
POAI Technical Analysis vs Fundamental Analysis
Sell
13
Predictive Oncology, Inc. (POAI)
is a Sell
Is Predictive Oncology, Inc. a Buy or a Sell?
-
Predictive Oncology, Inc. stock is rated a SellThe current Predictive Oncology, Inc. [POAI] share price is $5.51. The Score for POAI is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.